C
CRG
Private EquityActiveCRG is a market pioneer and innovator in healthcare investing that focuses on intellectual property investments in biopharmaceutical assets.
48
Investments
28
Exits
$1.6B
AUM
58.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for CRG.
Investment Thesis & Strategy
CRG invests in various stages of fintech, healthcare, and intellectual property companies, with a focus on biopharmaceutical assets.
Investment Activity
Deals per year over the last 11 years
2
20080
20090
20102
20111
20120
20132
20142
20151
20161
20171
2018Portfolio Companies
Selected investments from their portfolio of 48 companies
X
Xeris Biopharma
Biotech · Series A, 2018
O
Obsidian Therapeutics
Biotech · Series A, 2017
B
Biohaven Pharmaceutical
Biotech · Series A, 2016
A
Aprea Therapeutics
Biotech · Series A, 2015
V
Voyager Therapeutics
Biotech · Series A, 2015
A
Aeglea BioTherapeutics
Biotech · Series A, 2014
R
Rhythm Pharmaceuticals
Biotech · Series A, 2014
P
Protagonist Therapeutics
Biotech · Series A, 2012
R
Radius Health
Biotech · Series A, 2011
A
Aratana Therapeutics
Biotech · Series A, 2011
T
Tetraphase Pharmaceuticals
Biotech · Series A, 2008
E
Esperion Therapeutics
Biotech · Series A, 2008
Frequently Asked Questions
CRG focuses on Series B, Series C+ stage investments.
Related Investors
Main Street Capital
Houston, United States · 75 deals
Quantum Energy Partners
Houston, United States · 9 deals
Crest Capital Ventures
Houston, United States · 9 deals
Pelican Energy Partners
Houston, United States · 7 deals
SCF Partners Ltd.
Houston, United States · 6 deals
EnCap Investments
Houston, United States · 6 deals